Pirfenidone Tablet, Film Coated
Product Images NDC 69238-1640

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 69238-1640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Pirfenidone Tablets 1)

Chemical structure diagram of Pirfenidone showing its molecular formula and arrangement of atoms including a phenyl group, methyl group, nitrogen atom, and ketone functional group.*

FDA Label Image

Figure 1 (Pirfenidone Tablets 2)

A line graph comparing the percentage of patients experiencing changes in percent Forced Vital Capacity (%FVC) from baseline to week 52 between Pirfenidone and placebo groups. The x-axis shows absolute change in %FVC, and the y-axis shows the percentage of patients. The graph illustrates worsening and no decline sections, with numerical markers highlighting 32% vs. 17% worsening and 90% vs. 77% no decline for placebo and Pirfenidone, respectively.*

FDA Label Image

Figure 2 (Pirfenidone Tablets 3)

A line graph depicting the mean change in forced vital capacity (FVC) in milliliters (mL) over 52 weeks. The graph compares two groups: Pirfenidone (solid line) and Placebo (dashed line), showing a slower decline in FVC for the Pirfenidone group compared to Placebo across the study duration.*

FDA Label Image

Figure 3 (Pirfenidone Tablets 4)

A Kaplan-Meier survival curve chart comparing the percentage of patients alive over time (in weeks) between Pirfenidone and placebo groups. It includes numbers of patients at risk at various time points and a hazard ratio (HR) with 95% confidence interval (CI) depicted on the graph.*

FDA Label Image

267 mg Label (Pirfenidone Tablets 5)

Label for Pirfenidone Tablets 267 mg film-coated oral tablets by Amneal Pharmaceuticals LLC. The label indicates the tablet strength of 267 mg, package quantity of 90 tablets, and dosage directions to see the package insert. The label includes storage instructions and distributor information for Amneal Pharmaceuticals in Bridgewater, NJ.*

FDA Label Image

267 mg Carton (Pirfenidone Tablets 6)

Flat packaging label for Pirfenidone Tablets 267 mg film-coated tablets by Amneal Pharmaceuticals NY LLC. The label indicates a quantity of 270 tablets, divided into 3 bottles of 90 tablets each. The label includes storage instructions, dosage note, and emphasizes Rx only use.*

FDA Label Image

801 mg Label (Pirfenidone Tablets 7)

Label for Pirfenidone 801 mg film-coated tablets from Amneal Pharmaceuticals NY LLC. The label states each tablet contains 801 mg of pirfenidone and includes storage instructions to keep at 20° to 25°C with permitted excursions. The package contains 90 tablets and is for prescription use only.*

FDA Label Image

801 mg Carton (Pirfenidone Tablets 8)

Pirfenidone Tablets 801 mg film-coated tablet packaging label by Amneal Pharmaceuticals LLC. The label shows the product name, strength 801 mg, a depiction of the brown tablet, and contains storage instructions, dosage guidance reference, and quantity of 90 tablets. The label includes the NDC 69238-1641 and distributor information for Amneal Pharmaceuticals NY LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.